Showing 2601-2610 of 2652 results for "".
- Clearside Biomedical Phase 3 PEACHTREE Trial Results Presented at ASRShttps://modernod.com/news/clearside-biomedical-phase-3-peachtree-trial-results-presented-at-asrs/2479980/Steven Yeh, MD, presented data from the phase 3 PEACHTREE trial at the American Society of Retina Specialists annual meeting as a late-breaking oral presentation. This was the first public presentation of data from PEACHTREE, a pivotal phase 3 trial of suprachoroidal CLS-TA in patients with macul
- Family Income, Ethnicity, and Health Literacy May Affect Children’s Vision, Eye Care Accesshttps://modernod.com/news/family-income-ethnicity-and-health-literacy-may-affect-childrens-vision-eye-care-access/2479982/August for many children in the United States is the beginning of a brand new school year. According to the recent report from the National Center for Children’s Vision and Eye H
- A Daily Orange May Reduce AMD Risk, Study Findshttps://modernod.com/news/a-daily-orange-may-reduce-amd-risk-study-finds/2479986/People who consume at least one orange per day have a 60% lower risk of developing age-related macular degeneration (AMD) 15 years later compared with those who do not eat oranges, a study has found, according to a report in Medscape.
- Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Boardhttps://modernod.com/news/alzheimers-therapeutics-research-leader-dr-roy-twyman-joins-neurovision-imaging-board/2480013/Roy Ervin Twyman, MD, PhD, an academic neurologist with nearly 20 years’ experience in neuroscience pharmaceutical drug development, will join the NeuroVision Imaging Board of Directors on July 20. NeuroVision is developing and studying an experimental, breakthrough, low-cost, noninvasive,
- BlephEx Names Fred Ellis CEOhttps://modernod.com/news/blephex-names-fred-ellis-ceo/2480014/BlephEx has announced that Fred Ellis is the company’s new CEO. Mr. Ellis comes to BlephEx with 29+ years of experience with Alcon-Novartis. While there, he held numerous positions of increased responsibility overseeing a wide range of commercial assignments. He is recognized for having exception
- Practice-Hospital Consolidation Increasing for Many Specialtieshttps://modernod.com/news/practice-hospital-consolidation-increasing-for-many-specialties/2480021/The level of integration of certain primary care practices into health systems and hospitals more than doubled in recent years, with steeper increases seen in the fields of oncology and cardiology, according to research publish
- Zeiss Names New Chief Financial Officerhttps://modernod.com/news/zeiss-names-news-chief-financial-officer/2480025/Christian Müller, PhD, will become Chief Financial Officer of Carl Zeiss AG, succeeding Thomas Spitzenpfeil who, as previously announced, will leave the company. Dr. Müller has been CFO of the Zeiss subsidiary Carl Zeiss Meditec AG since 2009. He joined the Zeiss Group in 2002 as head of Corporat
- American Academy of Optometry Announces 2018 Award Recipientshttps://modernod.com/news/american-academy-of-optometry-announces-2018-award-recipients/2480026/Each year the American Academy of Optometry recognizes distinguished individuals who have made countless important contributions to advancing the profession of optometry. “Every nominee represents exactly what the American Academy
- Eyenovia Appoints Michael Rowe as Vice President of Marketinghttps://modernod.com/news/eyenovia-appoints-michael-rowe-as-vice-president-of-marketing/2480038/Eyenovia announced the appointment of Michael Rowe as Vice President of Marketing. Mr. Rowe is a veteran marketing professional with more than 20 years of experience in commercializing products and devices in the United States and globally across the healthcare industry.
- Katena Products Announces the Acquisition of Blink Medicalhttps://modernod.com/news/katena-products-announces-the-acquisition-of-blink-medical/2480044/Katena Products announced the purchase of Blink Medical, a UK-based provider of primarily single use ophthalmic instruments. Terms of the deal were not announced. Founded in 2004, Blink Medical currently distributes its products within Europe and the Middle East.